GALT
Galectin Therapeutics Inc
3.70$
-4.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 91.3% | 89.0% | 87.3% | 96.2% | 97.4% | 94.6% | 93.3% | 77.9% | 54.0% | 69.7% | 98.3% | 98.3% | 99.5% | 99.8% | 99.9% | 100.0% | 100.0% | 91.8% | 98.1% | 99.5% | 99.5% | 100.0% | 96.6% | 98.3% | 98.6% | 99.5% | |
| 91.3% | 84.4% | 84.1% | 95.1% | 96.3% | 90.0% | 12.1% | 74.0% | 45.2% | 57.6% | 93.5% | 96.7% | 97.9% | 97.9% | 98.2% | 97.9% | 97.3% | 73.4% | 91.6% | 98.0% | 91.7% | 94.8% | 87.3% | 91.0% | 86.4% | 90.7% | |
| 91.3% | 84.4% | 84.1% | 95.1% | 96.3% | 90.0% | 90.7% | 74.0% | 45.2% | 57.6% | 93.5% | 96.7% | 97.9% | 97.9% | 98.2% | 97.9% | 97.3% | 73.4% | 91.6% | 98.0% | 91.7% | 94.8% | 87.3% | 91.0% | 86.4% | 90.7% | |
| – | – | – | – | – | – | – | – | – | – | 3.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | 6.3% | 7.8% | 1.8% | 0.9% | 1.2% | 1.8% | 4.1% | 5.7% | 3.9% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.2% | 0.2% | 0.0% | – | – | – | – | |
| 4.3% | 3.2% | 3.7% | 0.0% | 1.4% | 4.2% | 4.0% | 14.0% | 32.0% | 12.8% | 0.6% | 0.5% | 0.3% | 0.2% | 0.1% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 4.3% | 3.2% | 3.7% | 1.7% | 1.4% | 4.2% | 4.0% | 14.0% | 32.0% | 12.8% | 0.6% | 0.5% | 0.3% | 0.2% | 0.1% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 78.3% | 31.2% | 29.2% | 4.7% | 9.0% | 27.8% | 100.3% | 264.1% | 166.6% | 1,124.5% | 126.9% | 33.5% | 17.2% | 23.2% | 5.7% | 5.1% | 23.9% | 71.3% | 23.4% | 5.9% | 18.3% | 93.7% | 251.3% | 313.6% | 689.1% | 746.1% | |
| 78.3% | 31.2% | 29.2% | 4.7% | 9.0% | 27.8% | 94.1% | 145.9% | 153.3% | 241.3% | 28.1% | 33.5% | 17.1% | 23.2% | 5.7% | 5.1% | 23.9% | 71.3% | 23.4% | 5.8% | 18.2% | 21.6% | 61.1% | 55.6% | 202.4% | 41.1% | |
| 34.8% | 11.0% | 0.7% | – | – | – | – | – | 28.4% | – | 9.3% | – | – | – | – | – | – | – | – | 0.1% | 0.1% | 0.0% | 0.2% | 0.2% | 120.8% | 0.1% | |
| 34.8% | 13.4% | 13.3% | 2.1% | 1.9% | 5.9% | 5.3% | 33.7% | 63.5% | 50.7% | 2.0% | 5.8% | 4.2% | 7.1% | 3.1% | 1.7% | 5.8% | 14.6% | 3.3% | 3.4% | 4.4% | 4.3% | 18.3% | 22.8% | 32.3% | 16.6% | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 69.4% | 187.1% | 254.4% | 486.5% | 684.7% | |
| 21.7% | 68.8% | 70.8% | 95.3% | 91.0% | 72.2% | -0.3% | -164.1% | -66.6% | -1,024.5% | -26.9% | 66.5% | 82.8% | 76.8% | 94.3% | 94.9% | 76.1% | 28.7% | 76.6% | 94.1% | 81.7% | 6.3% | -151.3% | -213.6% | -589.1% | -646.1% | |
| -82.6% | -235.4% | -343.1% | -158.8% | -179.0% | -532.5% | -404.3% | -1,973.1% | -5,475.9% | -10,943.8% | -895.6% | -1,045.6% | -836.9% | -951.8% | -400.7% | -530.3% | -1,036.4% | -4,354.0% | -2,178.7% | -446.5% | -810.8% | -647.2% | -1,454.4% | -1,256.6% | -2,295.4% | -2,214.6% | |
| 895.7% | 128.3% | 119.5% | 44.5% | 38.6% | 91.7% | 74.6% | 364.6% | 1,108.3% | 1,845.3% | 148.9% | 181.3% | 158.3% | 157.5% | 73.6% | 91.3% | 185.0% | 853.7% | 437.6% | 107.8% | 192.7% | 139.9% | 279.0% | 213.3% | 356.2% | 327.2% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.